Redhill Biopharma Ltd.
Sector: Manufacturing
Industry: Pharmaceutical Products
8.20
-0.30
(-3.53%)
Volume:
2,535
52 week range:
6.43 - 82.00
Market Cap:
433.391M
Company Description:
RedHill Biopharma Ltd. primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections.